Results Non-linear mixed modelling showed the (amplitude/ mesor) ratio for seasonal change in log 25(OH)D to be predictive of log sPTH (estimate=0.057, 95 % CI (0.051, 0.063), p <0.0001). Therefore, individuals with a higher seasonal change in log 25(OH)D, adjusted for overall log 25(OH)D concentration, showed increased levels of log sPTH. There was a corresponding significant ability to predict the range of seasonal change in log 25(OH)D through the level of sCTX. Here, the corresponding parameter statistics were estimate= 0.528, 95 % CI (0.418, 0.638) and p ≤0.0001. Conclusions These findings suggest a possible detriment to bone health via increased levels of sPTH and sCTX in individuals with a larger seasonal change in 25(OH)D concentration. Further larger cohort studies are required to further investigate these preliminary findings.
Introduction
Globally, it has been shown that 25-hydroxyvitamin D (25(OH)D, vitamin D) concentration decreases with increasing geographical latitude [1] . Poor 25(OH)D status in Western societies has been associated with increased risk of chronic diseases such as osteoporosis, heart disease, cancer and diabetes as well as infectious and autoimmune diseases [2] . Due to their high northern latitude, the prevalence of vitamin D deficiency has been shown to be high in individuals living in Europe [3] and Canada [4] . The seasonal variability in UVB radiation at higher latitudes also leads to noticeable seasonal variation in serum 25(OH)D concentration in individuals in these countries [5, 6] . Indeed, these seasonal differences are large compared to that of rural-dwelling humans living closer to the equator [7] .
The situation is further complicated by the inter-individual variation in seasonal serum 25(OH)D within populations [8, 9] . Some individuals show far larger changes in serum 25(OH)D concentration than others across seasons. The reasons for these individual differences are not clear, but differences in sun exposure behaviour [8, 9] , ethnicity [8] [9] [10] and clothing style [8] may be responsible. Recent work in premenopausal UK women has shown that intra-individual (e.g. seasonal) factors are as important as inter-individual factors in determining vitamin D status [8] . The few studies that have investigated seasonal changes in 25(OH)D concentration have found that South Asians [8] [9] [10] and older people from all ethnic groups [11, 12] show less pronounced seasonal variation in their 25(OH)D concentration than other population sub-groups including younger adults and Caucasians.
Large seasonal changes in 25(OH)D concentration may have consequences for the activity of the hydroxylase enzymes that control vitamin D metabolism. These enzymes include 1-hydroxylase (CYP 27B1), which catalyses the conversion of the substrate 25 3 D] . The activity of the 1-hydroxylase enzyme is readily affected by changes in its 25(OH)D substrate. This is because, unlike many other enzymes, it is working well below its Michaelis-Menten constant (Km) at physiological concentrations of 25(OH)D. Therefore, large seasonal fluctuations in 25(OH)D substrate could cause large changes in the activity of the 1-hydroxylase enzyme [13] . In addition, theoretically, a long-term decline in levels over the course of the year will not allow the desired level of 1,25(OH) 2 D to be achieved until the decline finishes [14] . This suggests that individuals with large seasonal change in 25 There is no evidence to date as to whether regular large seasonal changes in 25(OH)D concentration have any effect on health. There has been some suggestion of potential harm, however, based on findings of increased risk of prostate and pancreatic cancers [16, 17] and findings of increased mortality [18] in individuals with high vitamin D status. It has been proposed that these detrimental effects could be due to seasonal changes in 25(OH)D rather than high 25(OH)D itself [14] . This is because individuals with high serum 25(OH)D concentrations tend to be those who show the most seasonal change in 25(OH)D. They are therefore potentially susceptible to the detrimental perturbations in the activity of the hydroxylase enzymes described above. This intriguing hypothesis proposed by Vieth [14] attempts to explain the increased cancer risk and begs the question as to whether seasonal fluctuation or 'cycling' of 25(OH)D could also be detrimental to other aspects of health. Indeed, a recent study suggested that flares in the autoimmune disease systemic lupus erythematosis may be precipitated by large changes in vitamin D status [19] . This finding suggests that the effects of seasonal changes in 25(OH)D may have more widespread implications for health than just cancer risk. It is unknown whether these large seasonal fluctuations in 25(OH)D may have an impact on bone health.
The paracrine and autocrine effects of 1,25(OH) 2 D, produced locally in bone cells by 1-hydroxylase from 25(OH)D, have been recently elucidated [20, 21] . However, not enough is currently known about hydroxylase enzyme activity in bone cells to assess whether fluctuations in the 25(OH)D substrate would have any detriment on their ability to produce 1,25(OH) 2 D in the correct quantities. Indeed, in bone cells, the 1-hydroxylase and 24-hydroxylase have been found to be positively coupled, unlike in kidney cells where they are inversely coupled [22] .
This paracrine and autocrine vitamin D activity is important for many bone cell processes, including mineralisation [23] and regulating osteoclast differentiation and activity [24] . It is unknown whether seasonal fluctuations in 25(OH)D concentration could cause adverse perturbations in this regulation and thus be detrimental to bone health. Some studies show that bone markers show seasonal variation [25] , but other studies do not [26] [8] were analysed. Only participants who had no diagnosis of any disorder of calcium homeostasis, who were not peri-menopausal or who were not currently taking any medication likely to affect bone, calcium or vitamin D metabolism were included in the study. Women who had been taking vitamin D supplements or cod liver oil supplements were excluded or asked to refrain from their use 3 months before and during the 12 months of the study. Further details of subject recruitment and D-FINES study background information can be found in Darling et al. [8] .
During D-FINES, subjects had blood taken between 0800 and 1000 hours in four seasons (summer, autumn, winter and spring) for the determination of 25 ethnic/menopausal groups, rather than to assess seasonal change in detail over the course of the year. Thus, for this subsequent analysis, where assessment of seasonal change was required in more detail, the actual visit date rather than season was used for each measurement and the data pooled.
In a subgroup of 65 women (South Asian, n = 30; Caucasian, n= 35; randomly selected from all the women who had successfully attended all four visits), blood samples were also assessed for the bone resorption marker sCTX. In accordance with the ethical standards laid down in the 1964 Declaration of Helsinki, ethical reviews were obtained from relevant research ethics committees (National Health Service NHS REC 06/Q1909/1 and University of Surrey EC/2006/19/ SBMS). Written informed consent was obtained from all participants.
Biochemical measurements
Serum CTX was measured using an electrochemiluminescent immunoassay (Roche cobas e411 automated analyser) at the University of Sheffield (Metabolic Bone Centre, Northern General Hospital, Sheffield, UK). Intra-assay coefficient of variation (CV) was 5.7 % (n =12, mean 0.19 ng/mL). Interassay CV was level 1 QC, 2.1 % (n =9, mean 0.30 ng/mL); level 2 QC, 3.6 % (n =9, mean 0.70 ng/mL); and level 3 QC, 6.6 % (n =9, mean 2.86 ng/mL). Serum 25(OH)D and sPTH were measured by the Vitamin D Research Group, University of Manchester as described in detail previously [8] . The laboratory participates successfully in the vitamin D quality assurance scheme (DEQAS) and is accredited to Quality Measurement Standards ISO 9001:2008 and ISO 13485:2003 [8] . Briefly, serum 25(OH)D was measured using the manual IDS enzyme immunoassay (Immunodiagnostic Systems Ltd, Boldon, Tyne and Wear, UK) [8] . Manufacturer's reference ranges were 19-58 ng/mL (48-144 nmol/L) but vary with season, sensitivity (2 ng/mL; 5 nmol/L), and intra-and interassay coefficients of variation (6 and 7 %, respectively; manufacturer's values). Serum intact parathyroid hormone was measured using the OCTEIA immunoenzymometric assay (Immunodiagnostic Systems Ltd, Boldon, Tyne and Wear, UK). The normal adult reference range is 0.8-3.9 pmol/L, sensitivity is 0.06 pmol/L and intra-and inter-assay CV is 4 and 6 %, respectively (manufacturer's values) [8] .
Non-linear mixed modelling analysis A non-linear mixed modelling approach was used to assess the hypothesis that individuals with a high degree of seasonal cycling of 25(OH)D would show increased bone resorption, as evidenced by increased [sCTX] and [sPTH] concentration. The 25(OH)D data and the sPTH data were not normally distributed, so 25(OH)D and sPTH were logarithmically transformed. The data for sCTX were normally distributed, as assessed by the Kolmogorov-Smirnov test, so they were not log transformed. Measurements for sPTH, sCTX and 25(OH)D were approximately equally spaced over a year with precise visit dates used in the analysis, rather than month or season. Demographic data were drawn from baseline data only.
As potential confounders, at all times, body mass index (BMI) and ethnic/menopausal group were included in the model. It was important to control for ethnicity and menopausal status as these two factors are also known to be associated with differences in vitamin D status and vitamin D metabolism. The four ethnic/menopausal subject groups in our dataset were postmenopausal Caucasian, premenopausal Caucasian, postmenopausal South Asian and premenopausal South Asian and were entered into the model as three dummy variables, statistically contrasting the first group (postmenopausal Caucasian) with the remainder. BMI was entered into the model as it is known to be associated with overall 25(OH)D [17, 27] and seasonal change in 25(OH)D [12] .
The modelling procedure was as follows: To investigate constants of proportionality with seasonal fluctuation in serum 25(OH)D for the first dependent variable (sPTH), the data were analysed for all the participants who had a complete set of four data points for sPTH and log 25(OH)D, as well as baseline data for BMI and ethnic/menopausal group. This was a total of 200 women (n =96, n =65, n =21 and n =18 in postmenopausal Caucasians, premenopausal Caucasians, postmenopausal Asians and premenopausal Asians, respectively). The procedure followed for the sCTX analysis was analogous to that for sPTH (see above). The equivalent data in this analysis were for 60 women (n =15, n =18, n =15 and n =12, respectively, in postmenopausal Caucasians, premenopausal Caucasians, postmenopausal Asians and premenopausal Asians, respectively).
The model was used to assess whether log sPTH concentration, corrected for confounding effects as described above, was proportional to the level of log 25(OH)D as well as to the amplitude of seasonal variation in log 25(OH)D divided by the mesor log 25(OH)D. It was important to adjust the amplitude by the mean log 25(OH)D concentration (mesor), in order to control for the confounding effects of overall mean 25(OH)D concentration. The individual participant's four data points for log 25(OH)D were modelled as a mean level specific to that participant, to which a sine wave of amplitude and angular off-set both also specific for that participant was added, as well as a random normally distributed error term. The two participant-specific variables, mean level and angular offset were modelled as mixed random effects with unstructured variance-covariance matrix.
The sPTH data were simultaneously regressed as sets of four within participant repeated measures (with unstructured variance-covariance matrix, also encompassing the effects of the above-mentioned two participant-specific variables) against the independent variables: level of 25(OH)D, ratio of amplitude to mean of log 25(OH)D (i.e. amplitude/mesor), ethnicity and menopausal status category and BMI. The whole procedure was repeated for sCTX as the dependent variable.
The non-linear mixed modelling analysis was conducted using the NLMIXED procedure of the SAS (SAS Institute, Cary, NC, USA) software suite. Regression parameters significantly different from zero within the limits of the conventional 95 % confidence interval were deemed statistically significant. Baseline participant statistics were analysed using PASW Statistics, Release Version 18.0.0 (SPSS Inc., 2009, Chicago, IL).
Results

Participant characteristics
Results are presented as mean (SD). Table 1 Tables 2 and 3 show the same information, but for the subsets of the cohort who were included in the sPTH and sCTX analyses due to having complete data for all relevant variables(n =200, sPTH; n =60, sCTX). As can be seen from comparing Table 1 (entire cohort) with that of Table 2 (sPTH analysis) and Table 3 (sCTX analysis), the women included in the sPTH and sCTX analyses were representative of the entire cohort. Tables 1 and 3 for confidence intervals), and median sPTH is the same (2.8-3.0 pmol/L) between the participants in the regression model and the whole cohort. This result for 25(OH)D was likely due to a more even split of South Asian and Caucasian women in the sCTX analysis. This is in contrast to the sPTH analysis whereby there were a higher number of Caucasians than South Asians.
Non-linear mixed modelling
The regression analysis is summarised in Table 4. Table 4 includes the effect sizes for the main model parameters, here defined as the absolute value of the quotient of the estimated value and the standard error. Thus defined, the effect size for a parameter is only an indication of how significantly different from 0 the value of the parameter is, i.e. it is an indication of how necessary it is to include, as opposed to excluding, that parameter in the model. However, apart from identifying the importance of including the parameter in the model, the effect size conveys no other information about the functioning of the model.
sPTH and sCTX analysis
For log sPTH, the regression coefficient (and SE) for the amplitude/mesor ratio of 25(OH)D was 0.057 (0.003) with a 95 % confidence interval (0.051, 0.063) (p <0.0001). The effect size was 19.0, which means that the estimated value for that parameter was 19 standard errors of the estimate removed from 0. This shows a significant positive relationship, after adjustment for confounders (BMI and ethnic/menopausal group), and indicates that the amplitude/mesor parameter for 25(OH)D was a significant predictor of log sPTH concentration. For sPTH, the regression coefficient (SE) for the level of 25(OH)D was −0.018 (0.001) with a 95 % confidence interval of (−0.020, −0.016) (p <0.0001). The effect size was 18.0, marginally smaller than for the coefficient referred to immediately above.
For sCTX, the regression coefficient for amplitude/mesor ratio of 25(OH)D had an estimated value of 0.528 (95 % confidence interval 0.418, 0.638; p ≤0.0001) which was also statistically significant so that conclusions analogous to the above follow. The effect size was 9.3, which means that the estimated value for that parameter is 9.3 standard errors of the estimate removed from 0.
For sCTX, the regression coefficient (SE) for the level of 25(OH)D was −0.105 (0.014) with a 95 % confidence interval of (−0.132, −0.078) (p <0.0001). The effect size was 7.5, marginally smaller than that for the coefficient referred to immediately above.
Post hoc power considerations
One of the objectives of the study was to investigate the relationship between sPTH and the seasonal variation in serum 25(OH)D, and the study results show power in excess of 99.9 % for this aim, adjusting for confounding effects. Another objective of the study was to investigate the relationship between n =96, n =65, n =21 and n =18 in postmenopausal Caucasians, premenopausal Caucasians, postmenopausal Asians and premenopausal Asians, respectively sPTH serum parathyroid hormone, sCTX serum C-terminal telopeptide of collagen, 25(OH)D serum 25-hydroxyvitamin D, n number of participants with measurements, IQR interquartile range a Dietary calcium was assessed using 4-day photograph-assisted diet diaries (as previously validated in the EPIC cohort) b Percentile sCTX and the seasonal variation in serum 25(OH)D, and the study results also show power in excess of 99.9 % for this aim, adjusting for confounding effects.
Discussion
This is the first study, to the authors' knowledge, that has examined the association between seasonal change in 25(OH)D and a marker of bone resorption. A significant positive relationship was observed between the seasonal change in 25(OH)D and sPTH, supporting our original hypothesis suggesting that those individuals with a higher seasonal change in 25(OH)D had a higher sPTH. There was also a statistically significant association between seasonal change in 25(OH)D and bone resorption, as measured by sCTX, so that similar conclusions to the above are applicable. The above findings suggest that the higher sPTH seen with increased seasonal change in 25(OH)D may translate into alterations in bone resorption. Indeed, the results for sCTX are not surprising. A concomitant increase in sCTX would be predicted due to the increased bone resorption implicated by increased sPTH levels. The trends observed for sPTH and sCTX in the current study lend support to Vieth's hypothesis [14] that large seasonal changes in 25(OH)D might be associated with some adverse health outcomes. Indeed, in this study, for both sPTH and sCTX, seasonal fluctuation (as expressed by the amplitude/ mesor ratio) had a (albeit marginally) larger predictive ability in explaining sPTH and sCTX than did the average concentration of 25(OH)D (as assessed by respective coefficient effect sizes). Thus, in this dataset, seasonal variation in 25(OH)D status had a marginally statistically more significant impact on sPTH and sCTX concentration than did overall 25(OH)D concentration.
It A limitation of the study findings is that they are generalisable only to Caucasian and South Asian women and may not be generalisable to other ethnic groups due to potential differences in vitamin D metabolism that may affect seasonal changes in 25(OH)D, sPTH and sCTX. A larger sample size for bone markers will be even more informative to clarify the relationship between seasonal fluctuation in 25(OH)D and bone resorption.
In future work, it will be important to assess markers of bone formation as well as resorption as overall bone turnover is important for bone health, not just bone resorption. It is possible that an increase in sPTH may trigger increased bone formation, so may it not necessarily be detrimental to bone health. Measurement of bone formation as well as bone resorption is required to investigate further whether an increase in sPTH is likely to be harmful in the longer term. It would also be useful in longitudinal research studies to assess whether structural changes in bone are associated with seasonal changes in 25(OH)D, in order to determine possible chronic effects on bone health. Indeed, even if seasonal fluctuation in 25(OH)D is detrimental to the activity of the bone vitamin D Definition of effect sizes: the absolute value of the quotient of the estimated value and the standard error. Thus defined, the effect size for a parameter is only an indication of how significantly different from 0 the value of the parameter is, i.e. it is an indication of how necessary it is to include, as opposed to excluding, that parameter in the model. The conventional 5 % significance level is met for a parameter when the effect size for that parameter meets or exceeds a value of 1.96. However, apart from identifying the importance of including the parameter in the model, the effect size conveys no other information about the functioning of the model hydroxylase enzymes, there could still be physiological adaptation to this in the long term.
Conclusions
This study shows that greater seasonal cycling of 25(OH)D is associated with increased sPTH concentration and with increased bone resorption. In terms of public health, this finding suggests vitamin D supplements should not necessarily be taken all year round and there may be justification for 'blunting' the rhythm of 25(OH)D concentration over the course of the year via wintertime-only supplementation. Furthermore, it suggests that seasonal variation in 25(OH)D, as well as overall concentration, should be considered when making recommendations as to optimal concentrations of 25(OH)D for health.
